The global equine healthcare market held US$ 626.2 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 4.0% during the forecast period from 2018 to 2026. Growing trend of horse breeding and horse riding for leisure purpose is the major growth factor of the equine healthcare market. Other factors such as growing incidence of equine infections and development of novel animal safety and health programs will continue to assist the growth of the market. Horse racing for gambling and leisure purpose is highly active in region such as North America, Europe and Asia Pacific which stimulates the demand for equine healthcare products in the region. The companies operating in the market are engaging in research and development of novel products to gain competitive edge in the market.
Market Synopsis
Drug Segment to Drive the Global Equine Healthcare Market
In 2017, drugs segment held the largest share in the global equine healthcare market owing to growing demand for therapeutic drugs for the treatment of various diseases. Horses are highly prone to diseases such as tetanus, equine encephalomyelitis, rabies, equine influenza, West Nile virus among others which needs to be taken care of. The drugs segment is further segmented in to anti-infective, anti-inflammatory and anti-parasitic drugs. Vaccines held the second largest market is projected to grow at a steady rate during the forecast period. Supplements and additives are expected to exhibit fastest growth rate due to high product launch and growing awareness regarding the benefits of supplements among the equine care takers.
Historical & Forecast Period
2016 – Historical Year
2017 – Base Year
2018-2026 – Forecast Period
This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments calculated for the forecast period from 2018 to 2026.
Report Scope by Segments
Equine healthcare market report furnishes quantitative analysis along with its latest market trends. The market is segmented based on product type, disease type, and geography.
By Product Type (2016–2026; US$ Mn)
By Disease Type (2016 – 2026; Mn)
Geography Segment (2016–2026; US$ Mn)
Market is studied in order to understand the current dynamics and future trends in the global equine healthcare market. The study includes market size and forecast for all considered segments presented in the report for the period from 2016 to 2026, along with respective compound annual growth rate (CAGRs) for the forecast period from 2018 to 2026, considering 2017 as the base year. The key players currently engaged in equine healthcare market include Zoetis, Bayer AG, Boehringer Ingelheim (Merial), Vetoquinol S.A., Purina Animal Nutrition LLC, Merck & Co. (Merck Animal Health) among others.
Key questions answered in this report
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global Equine Healthcare Market Portraiture
2.2. Global Equine Healthcare Market, by Product Type, 2017 (US$ Mn)
2.3. Global Equine Healthcare Market, by Disease Type, 2017 (US$ Mn)
2.4. Global Equine Healthcare Market, by Geography, 2017 (US$ Mn)
Chapter 3. Equine Healthcare: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Equine Healthcare Market, by Key Players, 2017
Chapter 4. Global Equine Healthcare Market, by Product Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Drug Type
4.2.1. Anti-Infective
4.2.2. Anti-Inflammatory
4.2.3. Parasiticides
4.2.4. Others
4.3. Vaccine Type
4.3.1. Inactivated
4.3.2. Live Attenuated
4.3.3. Recombinant
4.3.4. Others
4.4. Supplements and Additives
Chapter 5. Global Equine Healthcare Market, by Disease Type, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. West Nile Virus
5.3. Equine Rabies
5.4. Potomac Horse Fever
5.5. Tetanus
5.6. Equine Influenza
5.7. Equine Herpes Virus
Chapter 6. Global Equine Healthcare Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. North America Equine Healthcare Market Analysis, 2016 – 2026
6.1.1. North America Equine Healthcare Market, by Product Type, 2016 - 2026 (US$ Mn)
6.1.2. North America Equine Healthcare Market, by Disease Type, 2016 - 2026 (US$ Mn)
6.1.3. North America Equine Healthcare Market, by Country, 2016 – 2026 (US$ Mn)
6.1.3.1. U.S.
6.1.3.2. Canada
6.2. Europe Equine Healthcare Market Analysis, 2016 – 2026
6.2.1. Europe Equine Healthcare Market, by Product Type, 2016 - 2026 (US$ Mn)
6.2.2. Europe Equine Healthcare Market, by Disease Type, 2016 - 2026 (US$ Mn)
6.2.3. Europe Equine Healthcare Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.2.3.1. U.K.
6.2.3.2. Germany
6.2.3.3. Rest of Europe
6.3. Asia Pacific Equine Healthcare Market Analysis, 2016 – 2026
6.3.1. Asia Pacific Equine Healthcare Market, by Product Type, 2016 - 2026 (US$ Mn)
6.3.2. Asia Pacific Equine Healthcare Market, by Disease Type, 2016 - 2026 (US$ Mn)
6.3.3. Asia Pacific Equine Healthcare Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. China
6.3.3.2. Japan
6.3.3.3. Rest of Asia Pacific
6.4. Latin America Equine Healthcare Market Analysis, 2016 – 2026
6.4.1. Latin America Equine Healthcare Market, by Product Type, 2016 - 2026 (US$ Mn)
6.4.2. Latin America Equine Healthcare Market, by Disease Type, 2016 - 2026 (US$ Mn)
6.4.3. Latin America Equine Healthcare Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. Brazil
6.4.3.2. Mexico
6.4.3.3. Rest of Latin America
6.5. Middle East & Africa Equine Healthcare Market, 2016 – 2026
6.5.1. Middle East & Africa Equine Healthcare Market, by Product Type, 2016 - 2026 (US$ Mn)
6.5.2. Middle East & Africa Equine Healthcare Market, by Disease Type, 2016 - 2026 (US$ Mn)
6.5.3. Middle East & Africa Equine Healthcare Market, by Region, 2016 – 2026 (US$ Mn)
6.5.3.1. GCC
6.5.3.2. Rest of Middle East & Africa
Chapter 7. Company Profiles
7.1. Bayer AG (Bayer Animal Health)
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Boehringer Ingelheim
7.3. Ceva Sante Animale
7.4. Eli Lilly and Company
7.5. Equine Products U.K. Ltd.
7.6. Merck & Co. (Merck Animal Health)
7.7. Purina Animal Nutrition LLC
7.8. Vetoquinol S.A.
7.9. Zoetis
Note: Modification in the list of company profiles or scope of the study can be incorporated on request.
FIG 1. Equine Healthcare Market: Research Methodology
FIG 2. Equine Healthcare: Market Segmentation
FIG 3. Global Equine Healthcare Market, by Product Type, 2017 (US$ Mn)
FIG 4. Global Equine Healthcare Market, by Disease Type, 2017 (US$ Mn)
FIG 5. Global Equine Healthcare Market, by Geography, 2017 (US$ Mn)
FIG 6. Attractive Investment Proposition, by Geography, 2017
FIG 7. Competitive Analysis: Global Equine Healthcare Market, by Key Players, 2017
FIG 8. Global Anti-Infective Market in Equine Healthcare, 2016-2026 (US$ Mn)
FIG 9. Global Anti-Inflammatory Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 10. Global Parasiticides Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 11. Global Other Drugs Market kin Equine Healthcare, 2016-2026(US$ Mn)
FIG 12. Global Inactivated Vaccines Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 13. Global Live Attenuated Vaccines Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 14. Global Recombinant Vaccines Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 15. Global Other Vaccines Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 16. Global Supplement and Additives Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 17. Global West Nile Virus Disease Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 18. Global Equine Rabies Disease Market in Equine Healthcare , 2016-2026(US$ Mn)
FIG 19. Global Potomac Horse Fever Disease Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 20. Global Tetanus Disease Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 21. Global Equine Influenza Disease Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 22. Global Equine Herpes Virus Disease Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 23. U.S. Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 24. Canada Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 25. U.K. Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 26. Germany Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 27. Rest of Europe Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 28. China Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 29. Japan Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 30. Rest of Asia Pacific Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 31. Brazil Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 32. Mexico Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 33. Rest of Latin America Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 34. GCC Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 35. Rest of Middle East & Africa Equine Healthcare Market, 2016-2026 (US$ Mn)
TABLE 1 Global Equine Healthcare Market Portraiture
TABLE 2 Global Equine Healthcare Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Drug Type in Equine Healthcare Market, 2016 – 2026 (US$ Mn)
TABLE 4 Global Vaccine Type in Equine Healthcare Market, 2016 – 2026 (US$ Mn)
TABLE 5 Global Equine Healthcare Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 6 Global Equine Healthcare Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 7 North America Equine Healthcare Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 8 North America Equine Healthcare Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 9 North America Equine Healthcare Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 10 Europe Equine Healthcare Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 11 Europe Equine Healthcare Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 12 Europe Equine Healthcare Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific Equine Healthcare Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 14 Asia Pacific Equine Healthcare Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 15 Asia Pacific Equine Healthcare Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America Equine Healthcare Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 17 Latin America Equine Healthcare Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 18 Latin America Equine Healthcare Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East & Africa Equine Healthcare Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 20 Middle East & Africa Equine Healthcare Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 21 Middle East & Africa Equine Healthcare Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 22 Bayer AG (Bayer Animal Health): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Boehringer Ingelheim: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Ceva Sante Animale: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Eli Lilly and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Equine Products U.K. Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Merck & Co. (Merck Animal Health): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Purina Animal Nutrition LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Vetoquinol S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 Zoetis: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
